Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 17

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 11
Chunk 17
---
 and Restated 2019 Equity Incentive Plan (the “2019 Plan”) and the TuHURA 2024 Equity Incentive Plan (the “2024 Plan”).

Retirement Plans

TuHURA maintains a 401(k) plan for employees, although it does not currently make matching contributions to such plan. Except for the 401(k) plan, we have not had and currently do not have a pension or other retirement plan or a nonqualified deferred compensation plan.

Other Compensation

All NEOs are eligible to participate in our employee benefit plans, including our medical, dental, vision, life and disability insurance plans, in each case on the same basis as all other employees, provided that we pay all premiums for the medical, dental, and vision plans for our executive officers. For the NEOs, we pay for and on behalf of each NEO life insurance premiums. We generally do not provide perquisites or personal benefits to our NEOs, except in limited circumstances.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth certain information regarding outstanding stock options held by the named executive officers as of December 31, 2024. 

    Name
     
    Number ofSecuritiesUnderlyingUnexercisedOptions (#)Exercisable

    Number ofSecuritiesUnderlyingUnexercisedOptions (#)Unexercisable

    OptionExercisePrice ($)

    OptionExpirationDate

    Dr. James Bianco

    178,901

    -

    $
    3.69

    7/1/2031

    President and Chief Executive Officer

    23,853

    47,707
     
    (1)
     
    $
    3.69

    4/7/2033

    191,281
     
    (3)

    $
    4.14

    2/28/2034

    1,065,990
     
    (4)

    $
    4.94

    11/12/2034

    Dan Dearborn

    33,991

    -

    $
    2.42

    1/17/2026

    Chief Financial Officer

    68,439

    -

    $
    2.42

    12/20/2026

    155,046

    77,525
     
    (2)
     
    $
    3